Cargando…

Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes

OBJECTIVE: The associated risk of vascular disease following diagnosis of type 2 diabetes in people previously identified as having pre-diabetes in real-world settings is unknown. We examined the presence of microvascular and macrovascular disease in individuals with newly diagnosed type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Palladino, Raffaele, Tabak, Adam G, Khunti, Kamlesh, Valabhji, Jonathan, Majeed, Azeem, Millett, Christopher, Vamos, Eszter P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202749/
https://www.ncbi.nlm.nih.gov/pubmed/32332069
http://dx.doi.org/10.1136/bmjdrc-2019-001061
_version_ 1783529759117934592
author Palladino, Raffaele
Tabak, Adam G
Khunti, Kamlesh
Valabhji, Jonathan
Majeed, Azeem
Millett, Christopher
Vamos, Eszter P
author_facet Palladino, Raffaele
Tabak, Adam G
Khunti, Kamlesh
Valabhji, Jonathan
Majeed, Azeem
Millett, Christopher
Vamos, Eszter P
author_sort Palladino, Raffaele
collection PubMed
description OBJECTIVE: The associated risk of vascular disease following diagnosis of type 2 diabetes in people previously identified as having pre-diabetes in real-world settings is unknown. We examined the presence of microvascular and macrovascular disease in individuals with newly diagnosed type 2 diabetes by glycemic status within 3 years before diagnosis. RESEARCH DESIGN AND METHODS: We identified 159 736 individuals with newly diagnosed type 2 diabetes from the UK Clinical Practice Research Datalink database in England between 2004 and 2017. We used logistic regression models to compare presence of microvascular (retinopathy and nephropathy) and macrovascular (acute coronary syndrome, cerebrovascular and peripheral arterial disease) disease at the time of type 2 diabetes diagnosis by prior glycemic status. RESULTS: Half of the study population (49.9%) had at least one vascular disease, over one-third (37.4%) had microvascular disease, and almost a quarter (23.5%) had a diagnosed macrovascular disease at the time of type 2 diabetes diagnosis. Compared with individuals with glycemic values within the normal range, those detected with pre-diabetes before the diagnosis had 76% and 14% increased odds of retinopathy and nephropathy (retinopathy: adjusted OR (AOR) 1.76, 95% CI 1.69 to 1.85; nephropathy: AOR 1.14, 95% CI 1.10 to 1.19), and 7% higher odds of the diagnosis of acute coronary syndrome (OR 1.07, 95% CI 1.03 to 1.12) in fully adjusted models at time of diabetes diagnosis. CONCLUSIONS: Microvascular and macrovascular diseases are detected in 37%–24% of people with newly diagnosed type 2 diabetes. Pre-diabetes before diagnosis of type 2 diabetes is associated with increased odds of microvascular disease and acute coronary syndrome. Detection of pre-diabetes might represent an opportunity for reducing the burden of microvascular and macrovascular disease through heightened attention to screening for vascular complications.
format Online
Article
Text
id pubmed-7202749
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72027492020-05-13 Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes Palladino, Raffaele Tabak, Adam G Khunti, Kamlesh Valabhji, Jonathan Majeed, Azeem Millett, Christopher Vamos, Eszter P BMJ Open Diabetes Res Care Epidemiology/Health Services Research OBJECTIVE: The associated risk of vascular disease following diagnosis of type 2 diabetes in people previously identified as having pre-diabetes in real-world settings is unknown. We examined the presence of microvascular and macrovascular disease in individuals with newly diagnosed type 2 diabetes by glycemic status within 3 years before diagnosis. RESEARCH DESIGN AND METHODS: We identified 159 736 individuals with newly diagnosed type 2 diabetes from the UK Clinical Practice Research Datalink database in England between 2004 and 2017. We used logistic regression models to compare presence of microvascular (retinopathy and nephropathy) and macrovascular (acute coronary syndrome, cerebrovascular and peripheral arterial disease) disease at the time of type 2 diabetes diagnosis by prior glycemic status. RESULTS: Half of the study population (49.9%) had at least one vascular disease, over one-third (37.4%) had microvascular disease, and almost a quarter (23.5%) had a diagnosed macrovascular disease at the time of type 2 diabetes diagnosis. Compared with individuals with glycemic values within the normal range, those detected with pre-diabetes before the diagnosis had 76% and 14% increased odds of retinopathy and nephropathy (retinopathy: adjusted OR (AOR) 1.76, 95% CI 1.69 to 1.85; nephropathy: AOR 1.14, 95% CI 1.10 to 1.19), and 7% higher odds of the diagnosis of acute coronary syndrome (OR 1.07, 95% CI 1.03 to 1.12) in fully adjusted models at time of diabetes diagnosis. CONCLUSIONS: Microvascular and macrovascular diseases are detected in 37%–24% of people with newly diagnosed type 2 diabetes. Pre-diabetes before diagnosis of type 2 diabetes is associated with increased odds of microvascular disease and acute coronary syndrome. Detection of pre-diabetes might represent an opportunity for reducing the burden of microvascular and macrovascular disease through heightened attention to screening for vascular complications. BMJ Publishing Group 2020-04-23 /pmc/articles/PMC7202749/ /pubmed/32332069 http://dx.doi.org/10.1136/bmjdrc-2019-001061 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology/Health Services Research
Palladino, Raffaele
Tabak, Adam G
Khunti, Kamlesh
Valabhji, Jonathan
Majeed, Azeem
Millett, Christopher
Vamos, Eszter P
Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
title Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
title_full Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
title_fullStr Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
title_full_unstemmed Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
title_short Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
title_sort association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
topic Epidemiology/Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202749/
https://www.ncbi.nlm.nih.gov/pubmed/32332069
http://dx.doi.org/10.1136/bmjdrc-2019-001061
work_keys_str_mv AT palladinoraffaele associationbetweenprediabetesandmicrovascularandmacrovasculardiseaseinnewlydiagnosedtype2diabetes
AT tabakadamg associationbetweenprediabetesandmicrovascularandmacrovasculardiseaseinnewlydiagnosedtype2diabetes
AT khuntikamlesh associationbetweenprediabetesandmicrovascularandmacrovasculardiseaseinnewlydiagnosedtype2diabetes
AT valabhjijonathan associationbetweenprediabetesandmicrovascularandmacrovasculardiseaseinnewlydiagnosedtype2diabetes
AT majeedazeem associationbetweenprediabetesandmicrovascularandmacrovasculardiseaseinnewlydiagnosedtype2diabetes
AT millettchristopher associationbetweenprediabetesandmicrovascularandmacrovasculardiseaseinnewlydiagnosedtype2diabetes
AT vamoseszterp associationbetweenprediabetesandmicrovascularandmacrovasculardiseaseinnewlydiagnosedtype2diabetes